BCRX BioCryst Pharmaceuticals, Inc.

6.56
-0.02  -0.3%
Previous Close 6.58
Open 6.58
Price To book 121.85
Market Cap 483.85M
Shares 73,758,000
Volume 1,364,906
Short Ratio 8.88
Av. Daily Volume 932,936

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data released February 2016 - primary endpoint not met
BCX4161 - OPuS-2
Hereditary angioedema
Approved Dec 22 2014
Peramivir - Study 303
INFLUENZA ACUTE
Phase 2 data from Part 1 portion of trial due 1Q 2017.
BCX7353 - APeX-1
Reduce or eliminate attacks in HAE patients

Latest News

  1. Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals (BCRX) Stock?
  2. BioCryst Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : BCRX-US : February 17, 2017
  3. Coverage initiated on BioCryst Pharma by Ladenburg Thalmann
  4. BioCryst to Announce Fourth Quarter and Year End 2016 Financial Results February 27
  5. BioCryst Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : BCRX-US : January 31, 2017
  6. BioCryst plans for European launch of injectable flu therapy
  7. BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
  8. BioCryst Announces the Acceptance of Peramivir MAA Filing by the European Medicines Agency
  9. Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals (BCRX) Stock?
  10. BioCryst Pharmaceuticals, Inc. – Value Analysis (NASDAQ:BCRX) : January 23, 2017
  11. ETFs with exposure to BioCryst Pharmaceuticals, Inc. : January 20, 2017
  12. BioCryst Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : BCRX-US : January 20, 2017
  13. BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
  14. BioCryst Receives Health Canada Approval for RAPIVAB® for the Treatment of Influenza
  15. BioCryst to Present at the J.P. Morgan Healthcare Conference
  16. Can The Uptrend Continue for BioCryst Pharmaceuticals (BCRX)?
  17. Are Options Traders Betting on a Big Move in BioCryst (BCRX) Stock?
  18. A Trump Presidency May Be Good for Biotech
  19. ETFs with exposure to BioCryst Pharmaceuticals, Inc. : December 16, 2016
  20. ETFs with exposure to BioCryst Pharmaceuticals, Inc. : December 5, 2016